Research ArticleCancer

The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility

See allHide authors and affiliations

Science Signaling  19 Aug 2014:
Vol. 7, Issue 339, pp. ra78
DOI: 10.1126/scisignal.2005157

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article